Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 2, 2025

December 2, 2025

Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

GlobeNewswire

December 2, 2025

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

GlobeNewswire

December 2, 2025

Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order

GlobeNewswire

December 2, 2025

Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT

GlobeNewswire

December 2, 2025

PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

GlobeNewswire

December 2, 2025

rYojbaba Announces the Launch of AI-Powered Worker Risk Intelligence Platform

GlobeNewswire

December 2, 2025

PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)

GlobeNewswire

December 2, 2025

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

GlobeNewswire

December 2, 2025

CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation

GlobeNewswire

December 2, 2025

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

GlobeNewswire

December 2, 2025

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

GlobeNewswire

December 2, 2025

Gelteq to Present at Investor Summit Virtual on December 9, 2025

GlobeNewswire

December 2, 2025

CORRECTION: Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery

GlobeNewswire

December 2, 2025

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

GlobeNewswire

December 2, 2025

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

GlobeNewswire

December 2, 2025

SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025

GlobeNewswire

December 2, 2025

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

GlobeNewswire

December 2, 2025

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

GlobeNewswire

December 2, 2025

Flame Broiler Expands Offerings With Limited-Time, Health-Conscious Charbroiled Wings

GlobeNewswire

December 2, 2025

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin

GlobeNewswire